Cargando…

State of knowledge of Cameroonian drug prescribers on pharmacovigilance

INTRODUCTION: The present study conducted in Cameroon from June 2013 to February 2014 aimed to estimating the level of pharmacovigilance knowledge and practice of health professionals in Cameroon. METHODS: We conducted a descriptive cross-sectional survey on 149 health professionals in Cameroon from...

Descripción completa

Detalles Bibliográficos
Autores principales: Nde, Francis, Fah, Aimé Bernard Djitafo, Simo, Francis Ampère, Wouessidjewe, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450046/
https://www.ncbi.nlm.nih.gov/pubmed/26090028
http://dx.doi.org/10.11604/pamj.2015.20.70.3873
_version_ 1782373957410750464
author Nde, Francis
Fah, Aimé Bernard Djitafo
Simo, Francis Ampère
Wouessidjewe, Denis
author_facet Nde, Francis
Fah, Aimé Bernard Djitafo
Simo, Francis Ampère
Wouessidjewe, Denis
author_sort Nde, Francis
collection PubMed
description INTRODUCTION: The present study conducted in Cameroon from June 2013 to February 2014 aimed to estimating the level of pharmacovigilance knowledge and practice of health professionals in Cameroon. METHODS: We conducted a descriptive cross-sectional survey on 149 health professionals in Cameroon from June to September 2013. Data were analyzed using software IBM SPSS 20.0. We calculated proportions and odd ratio, and confident interval of their values, keeping a threshold of p of 0.05 to determine the level of significance. RESULTS: Ninety percent (90%) of declaration of side effects were made to the medical representatives and 4% to the National Pharmacovigilance Centre. Fifty four percent (54%) of physicians were not aware of the existence of a National Pharmacovigilance system. Ten (10%) of prescribers had never heard of pharmacovigilance, however respondents answered unanimously that they need training on pharmacovigilance. A wrong definition was given by most of the nurses and dentists (61,1% and 58,3% respectively) as compared to physicians and pharmacists (respectively 15.2% and 26,5%). Given the results of this study, the establishment of a National Pharmacovigilance system based on a solid legal foundation is necessary in Cameroon. This implementation must go through the involvement of all stakeholders and their awareness raising on the importance of this activity and its positive impact on the health of populations. CONCLUSION: Pharmacovigilance is a public health problem in Cameroon, with due to lack of good knowledge and practice of prescribers, precisely physicians, pharmacists, nurses, and dentists who are not always aware of an existing pharmacovigilance system in Cameroon.
format Online
Article
Text
id pubmed-4450046
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-44500462015-06-18 State of knowledge of Cameroonian drug prescribers on pharmacovigilance Nde, Francis Fah, Aimé Bernard Djitafo Simo, Francis Ampère Wouessidjewe, Denis Pan Afr Med J Research INTRODUCTION: The present study conducted in Cameroon from June 2013 to February 2014 aimed to estimating the level of pharmacovigilance knowledge and practice of health professionals in Cameroon. METHODS: We conducted a descriptive cross-sectional survey on 149 health professionals in Cameroon from June to September 2013. Data were analyzed using software IBM SPSS 20.0. We calculated proportions and odd ratio, and confident interval of their values, keeping a threshold of p of 0.05 to determine the level of significance. RESULTS: Ninety percent (90%) of declaration of side effects were made to the medical representatives and 4% to the National Pharmacovigilance Centre. Fifty four percent (54%) of physicians were not aware of the existence of a National Pharmacovigilance system. Ten (10%) of prescribers had never heard of pharmacovigilance, however respondents answered unanimously that they need training on pharmacovigilance. A wrong definition was given by most of the nurses and dentists (61,1% and 58,3% respectively) as compared to physicians and pharmacists (respectively 15.2% and 26,5%). Given the results of this study, the establishment of a National Pharmacovigilance system based on a solid legal foundation is necessary in Cameroon. This implementation must go through the involvement of all stakeholders and their awareness raising on the importance of this activity and its positive impact on the health of populations. CONCLUSION: Pharmacovigilance is a public health problem in Cameroon, with due to lack of good knowledge and practice of prescribers, precisely physicians, pharmacists, nurses, and dentists who are not always aware of an existing pharmacovigilance system in Cameroon. The African Field Epidemiology Network 2015-01-27 /pmc/articles/PMC4450046/ /pubmed/26090028 http://dx.doi.org/10.11604/pamj.2015.20.70.3873 Text en © Francis Nde et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Nde, Francis
Fah, Aimé Bernard Djitafo
Simo, Francis Ampère
Wouessidjewe, Denis
State of knowledge of Cameroonian drug prescribers on pharmacovigilance
title State of knowledge of Cameroonian drug prescribers on pharmacovigilance
title_full State of knowledge of Cameroonian drug prescribers on pharmacovigilance
title_fullStr State of knowledge of Cameroonian drug prescribers on pharmacovigilance
title_full_unstemmed State of knowledge of Cameroonian drug prescribers on pharmacovigilance
title_short State of knowledge of Cameroonian drug prescribers on pharmacovigilance
title_sort state of knowledge of cameroonian drug prescribers on pharmacovigilance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450046/
https://www.ncbi.nlm.nih.gov/pubmed/26090028
http://dx.doi.org/10.11604/pamj.2015.20.70.3873
work_keys_str_mv AT ndefrancis stateofknowledgeofcamerooniandrugprescribersonpharmacovigilance
AT fahaimebernarddjitafo stateofknowledgeofcamerooniandrugprescribersonpharmacovigilance
AT simofrancisampere stateofknowledgeofcamerooniandrugprescribersonpharmacovigilance
AT wouessidjewedenis stateofknowledgeofcamerooniandrugprescribersonpharmacovigilance